Eric Walker added Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval - The New York Times to LY-CoV555

Eric Walker added Lilly antibody drug fails in a COVID-19 study; others go on to LY-CoV555

Eric Walker added Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern | Reuters to LY-CoV555

Eric Walker added Covid-19 News: Live Updates - The New York Times to Johnson & Johnson COVID-19 vaccine and LY-CoV555

Eric Walker added Coronavirus Antibody: Clinical Trials of Drugs Are Taking Longer Than Expected - The New York Times to Regeneron (Covid-19 treatment) and LY-CoV555

Eric Walker added a number of topics and a number of links to Covid-19 antibody treatments, and added Covid-19 antibody treatments to Covid-19 treatments and Covid-19 antibodies and immunity to Covid-19

Eric Walker added a number of links to LY-CoV555, and added LY-CoV555 to Covid-19 antibody treatments, Eli Lilly and New and investigational drugs

Eric Walker added LY-CoV555 and Oritavancin and The Danger of President Pence | The New Yorker and Warning of ‘Pig Zero’: One Drugmaker’s Push to Sell More Antibiotics - The New York Times to Eli Lilly, and added Eli Lilly to Pharmaceutical makers and biopharmaceutical companies and Organizations and businesses in Indiana

Eric Walker added a number of topics to New and investigational drugs, and added New and investigational drugs to Medications